-
Sekisui XenoTech Receives New US Patent for Kit and Method to Evaluate Xenobiotic Drug Metabolism in Hepatocytes
Jul 17, 2018, 08:49 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Jul 17, 2018 - Sekisui XenoTech has been awarded US patent # 10,001,471 "In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytesFull story -
Government Insurers Balk At Paying For CAR-T Cancer Drug
Jul 17, 2018, 08:44 AM by Michael CroftNPR | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.Full story -
Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia
Jul 17, 2018, 05:30 AM by Michael CroftDUBLIN, IRELAND - Jul 17, 2018 - Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced the publication of preclinical data showing the companys dual mechanism PIM/PI3 kinase inhibitor IBL-202 has promise as a treatment for chronic lymphocytic leukaemia (CLL)Full story -
Another CRISPR Calamity? U.K. Team Reports CRISPR-Induced Gene Rearrangements
Jul 16, 2018, 12:38 PM by Michael CroftGEN | Scientists at the Wellcome Sanger Institute in the U.K. have reported another potential hurdle for the CRISPR community, publishing findings today that call the precision of CRISPR-Cas9 gene editing into question.Full story -
Rho Offers Tips for Cellular Therapy Studies
Jul 16, 2018, 12:32 PM by Michael CroftCHAPEL HILL, NC - Jul 17, 2018 - For Immediate Release Rho Offers Tips for Cellular Therapy StudiesCRO shares challenges for cellular therapy in clinical trials Chapel Hill, NC ̶ July 16, 2018 Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, offers tips on overcoming the challenges associated with cellular therapy clinical trialsFull story -
Leading Alzheimer's Disease scientist joins NeuroCog Trials
Jul 16, 2018, 11:34 AM by Michael CroftDURHAM, NC, US - Jul 16, 2018 - Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimers Disease (AD) research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice President of Neurodegenerative DisordersFull story -
Leaders In Biobanking Congress: Unlocking The Potential
Jul 16, 2018, 11:25 AM by Michael CroftFull storyBio-IT World | This year, the 10th annual Leaders in Biobanking Congress will take place in Cleveland, Ohio from October 14-16. Biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners will converge to discuss the various aims for biospecimen collections, from basic research to clinical trials.
-
MR Solutions installs Hawaii’s first preclinical MRI imaging system
Jul 16, 2018, 08:18 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Jul 16, 2018 - MR Solutions has installed Hawaiis first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through researchFull story -
Protein Dynamic Solutions named to “The most valuable venture-backed startups in all 50 states”
Jul 15, 2018, 18:20 PM by Michael CroftWAKEFIELD, MA - Jul 16, 2018 - Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for structural characterization of therapeutic proteins, was recognized by Business Insiderfor provision of instruments and contract research services to the biopharmaceutical industryFull story -
Superbugs Win Another Round As Big Pharma Leaves Antibiotics
Jul 13, 2018, 10:26 AM by Michael CroftBloomberg | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan.Full story -
Wasdell Group launch serialisation service
Jul 12, 2018, 11:35 AM by Michael CroftSWINDON, UK - Jul 12, 2018 - The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlinesFull story -
I'm Adopted, Should I Have DNA Testing?
Jul 11, 2018, 10:02 AM by Michael CroftForbes | Should adoptees, or parents of adoptees, consider direct-to-consumer genetic testing kits to gain more information on health risks, ancestry, or to find biological relatives? A certified genetic counselor reviews the pros and cons you should know before you spit.Full story -
TraceLink Unveils Product Information Manager, a Standards-Based Network Application for Its Industry-Leading Digital Information Sharing Platform
Jul 10, 2018, 12:13 PM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Jul 10, 2018 - North Reading, MA (July 10, 2018)-TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced Product Information Manager (PIM), a standards-based network application built on TraceLink's end-to-end information-sharing platformFull story -
BioIVT Acquires Optivia, Adding Transporter Assay Products And Services To Its ADME-Tox Portfolio
Jul 9, 2018, 15:55 PM by Michael CroftFull storyBio-IT World Brief | BioIVT today announced that it has acquired Santa Clara, CA-based Optivia and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.
-
CluePoints Announces Four Year Partnership with ONO Pharmaceutical and Strengthens RBM Position in Japan
Jul 9, 2018, 09:04 AM by Michael CroftWAYNE, PA - Jul 9, 2018 - CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into a significant enterprise agreement with leading Japanese drug development organization, ONO Pharmaceutical CoFull story -
BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio
Jul 9, 2018, 08:27 AM by Michael CroftWESTBURY, NY - Jul 9, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutionsFull story -
JUWELS Becomes Germany’s Most Powerful Supercomputer
Jul 5, 2018, 08:11 AM by Michael CroftTOP500 | The first module of JUWELS, a supercomputer that is expected to be a model for future exascale systems, is now up and running at the Jülich Supercomputing Centre in Germany.Full story -
The Latest “Battle” of CDK4/6 inhibitors: Big Three Equally Matched
Jul 4, 2018, 05:22 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 4, 2018 - On June 13th, Beida Pharmaceutical announced that its self-developed BPI-16350 capsule has approved clinical trial application for breast cancer by China FDAFull story -
BC Platforms and Tieto partner to integrate genomic and clinical data management to advance precision medicine
Jul 3, 2018, 14:34 PM by Michael CroftBASEL, SWITZERLAND - Jul 3, 2018 - BC Platforms, a world leader in genomic data management and analytics, today announces that it has partnered with Tieto, one of the largest healthcare IT providers in Northern Europe, to advance precision medicine for Nordic healthcare providersFull story -
Why Data Science Is An Art – And How To Support The People Who Do It
Jul 3, 2018, 13:45 PM by Michael CroftFull storyElsevier Connect | In his recent talk at the Bio-IT World Conference, Elsevier’s Jabe Wilson used examples of data science undertaken at Elsevier to illustrate why data science is an art – and how best to support data scientists based on this insight.